The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Tyler, Simon Nicholas George, Dr
    Company Director born in August 1973
    Individual (7 offsprings)
    Officer
    2020-03-31 ~ now
    OF - Director → CIF 0
  • 2
    Burn, Ross Thomas, Dr
    Company Director born in February 1981
    Individual (10 offsprings)
    Officer
    2020-03-31 ~ now
    OF - Director → CIF 0
  • 3
    CATSCI HOLDINGS LTD
    Cbtc2 Capital Business Park, Wentloog, Cardiff, Wales
    Active Corporate (4 parents, 1 offspring)
    Person with significant control
    2022-03-10 ~ now
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
Ceased 4
  • 1
    Lumby, Gary
    Ned born in March 1958
    Individual (8 offsprings)
    Officer
    2020-07-13 ~ 2022-05-31
    OF - Director → CIF 0
  • 2
    Turp, Ed Robert, Dr
    Company Director born in December 1970
    Individual
    Officer
    2020-03-31 ~ 2022-03-10
    OF - Director → CIF 0
    Dr Ed Robert Turp
    Born in December 1970
    Individual
    Person with significant control
    2020-03-31 ~ 2022-03-10
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 3
    Dr Simon Nicholas George Tyler
    Born in August 1973
    Individual (7 offsprings)
    Person with significant control
    2020-03-31 ~ 2022-03-10
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
  • 4
    Ross Thomas Burn
    Born in February 1981
    Individual (10 offsprings)
    Person with significant control
    2020-03-31 ~ 2022-03-10
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
parent relation
Company in focus

CAPITAL DRUG DEVELOPMENT LTD

Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Intangible Assets
51,000 GBP2021-12-31
0 GBP2021-03-31
Fixed Assets - Investments
784,687 GBP2021-12-31
684,687 GBP2021-03-31
Fixed Assets
835,687 GBP2021-12-31
684,687 GBP2021-03-31
Debtors
65,050 GBP2021-12-31
20,941 GBP2021-03-31
Cash at bank and in hand
62,863 GBP2021-12-31
0 GBP2021-03-31
Current Assets
127,913 GBP2021-12-31
20,941 GBP2021-03-31
Creditors
Current, Amounts falling due within one year
-1,085,162 GBP2021-12-31
-499,099 GBP2021-03-31
Net Current Assets/Liabilities
-957,249 GBP2021-12-31
-478,158 GBP2021-03-31
Total Assets Less Current Liabilities
-121,562 GBP2021-12-31
206,529 GBP2021-03-31
Creditors
Non-current, Amounts falling due after one year
-200,000 GBP2021-12-31
-300,000 GBP2021-03-31
Net Assets/Liabilities
-321,562 GBP2021-12-31
-93,471 GBP2021-03-31
Equity
Called up share capital
300 GBP2021-12-31
300 GBP2021-03-31
Retained earnings (accumulated losses)
-321,862 GBP2021-12-31
-93,771 GBP2021-03-31
Equity
-321,562 GBP2021-12-31
-93,471 GBP2021-03-31
Average Number of Employees
42021-04-01 ~ 2021-12-31
42020-04-01 ~ 2021-03-31
Director Remuneration
84,767 GBP2021-04-01 ~ 2021-12-31
176,833 GBP2020-04-01 ~ 2021-03-31
Investments in group undertakings and participating interests
684,687 GBP2021-12-31
684,687 GBP2021-03-31
Other Investments Other Than Loans
100,000 GBP2021-12-31
0 GBP2021-03-31
Amounts invested in assets
Non-current
784,687 GBP2021-12-31
684,687 GBP2021-03-31
Other Debtors
Amounts falling due within one year
65,050 GBP2021-12-31
20,941 GBP2021-03-31
Trade Creditors/Trade Payables
Current
7,596 GBP2021-12-31
5,021 GBP2021-03-31
Amounts owed to group undertakings
Current
852,959 GBP2021-12-31
287,519 GBP2021-03-31
Other Creditors
Current
224,607 GBP2021-12-31
206,559 GBP2021-03-31
Creditors
Current
1,085,162 GBP2021-12-31
499,099 GBP2021-03-31
Other Creditors
Non-current
200,000 GBP2021-12-31
300,000 GBP2021-03-31

Related profiles found in government register
  • CAPITAL DRUG DEVELOPMENT LTD
    Info
    Registered number 12540893
    Cbtc2 Capital Business Park, Wentloog, Cardiff CF3 2PX
    Private Limited Company incorporated on 2020-03-31 (5 years 3 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-18
    CIF 0
  • CAPITAL DRUG DEVELOPMENT LTD
    S
    Registered number 12540893
    Cbtc 2, Capital Business Park, Wentloog, Cardiff, Wales, CF3 2PX
    Private Limited By Shares in Companies House Uk, England & Wales
    CIF 1
  • CAPITAL DRUG DEVELOPMENT
    S
    Registered number 12540893
    Cbtc2, Capital Business Park, Cardiff, United Kingdom
    Limited Company in Companies Hiuse, England And Wales
    CIF 2
child relation
Offspring entities and appointments
Active 2
  • 1
    Catsci Ltd, Cbtc2 Capital Business Park, Wentloog, Cardiff
    Active Corporate (4 parents)
    Profit/Loss (Company account)
    730,560 GBP2021-01-01 ~ 2021-12-31
    Person with significant control
    2020-04-29 ~ now
    CIF 1 - Ownership of shares – 75% or moreOE
    CIF 1 - Ownership of voting rights - 75% or moreOE
  • 2
    St. Philips Central, Unit Dx Albert Road, St. Philips, Bristol, Avon, United Kingdom
    Dissolved Corporate (2 parents)
    Person with significant control
    2020-07-04 ~ dissolved
    CIF 2 - Ownership of shares – 75% or moreOE
    CIF 2 - Ownership of voting rights - 75% or moreOE
    CIF 2 - Right to appoint or remove directorsOE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.